Abstract
The disappointing results of chemoprevention trials in human are certainly of concern. Negative results should not discourage us from looking into the positive effects of chemoprevention. However slight advances in cancer chemotherapy catch the attention of the world, and feeble positive results are also measured considerably, unlike in cancer chemoprevention. Another factor is that expectations from chemoprevention are too high and success is barely observed. If chemoprevention is proposed to be the future therapy for cancer, various other factors are required to be calculated seriously.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adhami VM et al (2013) Human cancer chemoprevention, hurdles and challenges. Top Curr Chem 329:203–220
Baron JA, Sandler RS, Bresalier RS et al (2006) A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 131:1674–1682
Bennett A, Tacca MD, Stamford IF et al (1977) Prostaglandins from tumours of human large bowel. Br J Cancer 35:881–884
De S (2011) Food, the omnivore’s labyrinth. Nature 471:S22–S24
Elmets CA, Viner JL, Pentland AP et al (2010) Chemoprevention of nonmelanoma skin cancer with celecoxib, a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst 102:1835–1844
Fournier DB, Gordon GB (2000) COX-2 and colon cancer, potential targets for chemoprevention. J Cell Biochem 34:97–102
Gasper AV, Al-Janobi A, Smith JA et al (2005) Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high glucosinolate broccoli. Am J Clin Nutr 82:1283–1291
Goss PE, Ingle JN, Ales-Martinez JE et al (2011) Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 364:2381–2391
Guyton KZ, Kensler TW, Posner GH (2003) Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutr Rev 61:227–238
Harper CE, Patel BB, Wang J et al (2007) Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice, mechanisms of action. Prostate 67:1576–1589
Lampe JW (2009) Is equal the key to the efficacy of soy foods? Am J Clin Nutr 89:1664S–1667S
Lampe JW (2010) Emerging research on equol and cancer. J Nutr 140:1369S–1372S
Lu H, Meng X, Yang CS (2003) Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by –.-epigallocatechin gallate. Drug Metab Dispos. The Biological Fate of Chemicals 31:572–579
Mukhtar H (2012) Chemoprevention, making it a success story for controlling human cancer. Cancer Lett 326(2):123–127
Rothwell PM, Wilson M, Elwin CE et al (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality, 20-year follow-up of five randomised trials. Lancet 376:1741–1750
Schmidt C (2011) The breast cancer chemoprevention debate. J Natl Cancer Inst 103:1646–1647
Siddiqui IA, Adhami VM, Bharali DJ et al (2009) Introducing nanochemoprevention as a novel approach for cancer control, proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res 69:1712–1716
Wu AH, Tseng CC, Van Den Berg D et al (2003) Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res 63:7526–7529
Wu X, Lippman SM (2011) An intermittent approach for cancer chemoprevention. Nat Rev Cancer 11:879–885
Wu X, Patterson S, Hawk E (2011) Chemoprevention-history and general principles. Best Pract Res Clin Gastroenterol 25:445–459
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Rashid, S. (2017). Cancer Chemoprevention: Hurdles and Future Prospects and Considerations. In: Cancer and Chemoprevention: An Overview. Springer, Singapore. https://doi.org/10.1007/978-981-10-2579-2_23
Download citation
DOI: https://doi.org/10.1007/978-981-10-2579-2_23
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-2578-5
Online ISBN: 978-981-10-2579-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)